Gossamer Bio Financial Overview
Gossamer Bio's market cap is currently $833.24M. The company's EPS TTM is $-0.21; its P/E ratio is ―; Gossamer Bio is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
